肿瘤转移抑制基因Kiss-1在非小细胞肺癌中的表达及其临床意义

    Expression of metastasis suppressor gene Kiss-1 in non-small cell lung carcinoma and its clinical significance

    • 摘要: 目的:观察肿瘤转移抑制基因Kiss-1在非小细胞肺癌(non-small cell lung cancer,NSCLC)中的表达情况,探讨其表达与NSCLC临床病理参数间的关系。方法:应用免疫组织化学EliVision二步法检测68例NSCLC患者癌组织及其癌旁组织中Kiss-1的表达,统计学分析表达结果与NSCLC的临床病理参数的关系。结果:NSCLC癌组织和癌旁组织中Kiss-1阳性率分别为82.4%和66.2%,两者差异有统计学意义(P<0.05)。有淋巴结转移和无淋巴结转移的NSCLC组织中Kiss-1阳性率分别为39.4%和91.4%;高、中分化和低、未分化的NSCLC组织中Kiss-1阳性率分别为82.5%和42.9%;Ⅰ+Ⅱ期和Ⅲa期NSCLC组织中Kiss-1阳性率分别为81.8%和37.5%,其差异均有统计学意义(P<0.01)。结论:有淋巴结转移、分化差和病理分期晚的NSCLC中Kiss-1表达下调或缺失,有望为NSCLC基因治疗提供理论依据。

       

      Abstract: Objective: To study the relationship between the expression downregulation or absence of metastasis suppressor gene Kiss-1 and clinicopathological parameters of non-small cell lung carcinoma (NSCLC).Methods: The expression of Kiss-1 was detected in the tumor and adjacent tissue in 68 paraffin sections of NSCLC by immunohistochemistry (EliVision methods),and the results were used to analyze the relationship with clinicopathological parameters.Results: The positive rate of Kiss-1 in tumor (82.4%) was significantly higher than that in adjacent tissue (66.2%) (P<0.05).The difference of positive rate of Kiss-1 was significant between group 1 (with metastasis of lymph node) and group 2 (without metastasis of lymph node).There was significant difference between the well differentiated,moderately differentiated group (82.5%) and the poorly differentiated,undifferentiated group (42.9%).Kiss-1 expression in the (Ⅰ+Ⅱ) stage (81.8%) was distinctly higher than that in the Ⅲ stage (37.5%) (P<0.01).Conclusions: In the patients of NSCLC,the expression of Kiss-1 is lower in the group with metastasis of lymph node,poor differentiation and advanced stage,which may provide a theoretical basis of gene therapy for NSCLC.

       

    /

    返回文章
    返回